Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy.
aristolochic acid
mouse model
nephropathy
xanthine oxidoreductase
Journal
FEBS open bio
ISSN: 2211-5463
Titre abrégé: FEBS Open Bio
Pays: England
ID NLM: 101580716
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
15
05
2020
revised:
02
12
2020
accepted:
24
12
2020
pubmed:
16
1
2021
medline:
15
12
2021
entrez:
15
1
2021
Statut:
ppublish
Résumé
Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage. Herein, we investigated the activity of XOR in a mouse model of aristolochic acid I (AA)-induced nephropathy, a type of nephrotoxic chronic kidney disease (CKD). A persistent decrease in renal function was observed in mice up to 4 weeks after 4 weeks of AA (2.5 mg kg
Identifiants
pubmed: 33448693
doi: 10.1002/2211-5463.13083
pmc: PMC7876505
doi:
Substances chimiques
Aristolochic Acids
0
aristolochic acid I
94218WFP5T
Xanthine Dehydrogenase
EC 1.17.1.4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
507-518Informations de copyright
© 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Références
Sci Rep. 2017 Apr 28;7(1):1266
pubmed: 28455534
Biochim Biophys Acta. 1998 Jul 23;1381(2):191-202
pubmed: 9685639
FASEB J. 1995 Aug;9(11):995-1003
pubmed: 7649415
Nat Commun. 2015 Mar 24;6:6555
pubmed: 25800347
Am J Kidney Dis. 2019 Mar;73(3):332-343
pubmed: 30454885
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:189-197
pubmed: 26673227
Hypertension. 2018 Jan;71(1):78-86
pubmed: 29203632
JCI Insight. 2017 Nov 16;2(22):
pubmed: 29202460
J Leukoc Biol. 2019 Feb;105(2):377-399
pubmed: 30589456
J Am Heart Assoc. 2015 Mar 19;4(3):e001594
pubmed: 25792129
Transl Res. 2015 Apr;165(4):512-30
pubmed: 25176603
Q Rev Biophys. 1988 Aug;21(3):299-329
pubmed: 3065813
Hypertension. 2009 Oct;54(4):868-76
pubmed: 19667249
Sci Rep. 2017 Oct 12;7(1):13086
pubmed: 29026167
J Clin Hypertens (Greenwich). 2019 Jul;21(7):966-974
pubmed: 31169986
Kidney Int. 2006 Feb;69(3):488-94
pubmed: 16514431
J Am Soc Nephrol. 2014 May;25(5):1013-27
pubmed: 24357671
Prog Exp Tumor Res. 2005;38:89-114
pubmed: 15746531
Pediatr Res. 1988 Feb;23(2):143-50
pubmed: 3281119
N Engl J Med. 1985 Jan 17;312(3):159-63
pubmed: 2981404
J Am Soc Nephrol. 1999 Oct;10(10):2146-57
pubmed: 10505691
Hypertension. 2001 Nov;38(5):1101-6
pubmed: 11711505
J Biochem. 1994 Jul;116(1):1-6
pubmed: 7798166
Kidney Int. 2014 Sep;86(3):570-81
pubmed: 24694992
Int J Cardiol. 2016 Jun 15;213:28-32
pubmed: 26318389
Mediators Inflamm. 2016;2016:8603164
pubmed: 28070145
Nephron Extra. 2013 Jan 11;3(1):12-29
pubmed: 23610565
Am J Physiol. 1997 Feb;272(2 Pt 1):G281-8
pubmed: 9124352
Hypertension. 2013 May;61(5):948-51
pubmed: 23460277
Kidney Int. 2012 Nov;82(10):1105-13
pubmed: 22854641
Hypertension. 2013 Jun;61(6):1203-10
pubmed: 23529167
Nephrol Dial Transplant. 2007 Jun;22(6):1512-7
pubmed: 17405785
Monatsh Chem. 2017;148(11):1971-1981
pubmed: 29104318
Mol Immunol. 2018 Nov;103:115-124
pubmed: 30248487
Am J Pathol. 2008 Sep;173(3):631-42
pubmed: 18688035
Arch Toxicol. 2016 Nov;90(11):2595-2615
pubmed: 27538407
Lancet. 2016 Oct 22;388(10055):2039-2052
pubmed: 27112094
Am J Nephrol. 2006;26(4):363-71
pubmed: 16873992
Am J Kidney Dis. 2000 Feb;35(2):313-8
pubmed: 10676733
Genes Dev. 2002 Dec 15;16(24):3223-35
pubmed: 12502743
Cell Metab. 2007 Feb;5(2):115-28
pubmed: 17276354
Sci Rep. 2017 Oct 25;7(1):14004
pubmed: 29070821
FEBS Lett. 2018 Jun;592(12):2126-2139
pubmed: 29749013